Biosergen
0.62 SEK -4.62%1 investor is following this company
Biosergen is a biotechnology company. The company specializes in the research and development of various pharmaceuticals. The product portfolio includes, for example, the company's product BSG005, a fungicidal pharmaceutical in the clinical phase. In addition to the main business, service and associated ancillary services are also offered. The company operates in Norway. Biosergen was founded in 2004 and is headquartered in Solna.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
BIOSGN
Daily low / high price
0.62 / 0.65
SEK
Market cap
88.28M SEK
Turnover
132.38K SEK
Volume
208K
Financial calendar
Interim report
2024-11-29
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Östersjöstiftelsen | 47.8 % | 47.8 % |
Ribbskottet Aktiebolag | 14.1 % | 14.1 % |
Rosetta Capital IV Sarl | 10.2 % | 10.2 % |
Tuvedalen Limited | 5.3 % | 5.3 % |
ShowingAll content types
Carlsquare: Research update Biosergen: First patient treated in phase Ib study a success
Biosergen AB: BioStock: Biosergens vd: "The first patient regained his health"
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools